Back to search
FDAFDA · Food and drugs·Recall number Z-3120-2017

Cell Marque, Podoplanin (D2-40 Mab), 7 mL, REF PA0796, IVD, The antibody is intended for in vitro diagnostic (IVD) use. The Podoplanin (D2-40) antibody is intended for qualified laboratories to qualitatively identify by light microscopy the presence of associated antigens in sections of formalin-fixed, paraffin-embedded tissue sections using IHC test methods

Published September 20, 2017 · Recall initiated: July 14, 2017

Summary

FDA records medical device Class II recall Z-3120-2017, published September 20, 2017 and initiated July 14, 2017. Recalling firm: Leica Biosystems Richmond Inc.; Status: Terminated; Reported quantity: 4; Lot: Product Code PA0796, Lot No. 47793, Exp. Date 09/24/2019. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

A delay in transit may have contributed to nonconformity as the product was stored outside of defined shipping and handling temperature requirements.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Leica Biosystems Richmond Inc.
Distributor
Nationwide Distribution to AR, AZ, CA, CT, FL, GA, IL, IN, KY, LA, MI, MN, NC, NH, NV, NY, OR, PA, SC, TN, TX, VA, and WI.
Lot
Product Code PA0796, Lot No. 47793, Exp. Date 09/24/2019
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Cell Marque, Podoplanin (D2-40 Mab), 7 mL, REF PA0796, IVD, The antibody is intended for in vitro diagnostic (IVD) use. The Podoplanin (D2-40) antibody is intended for qualified laboratories to qualitatively identify by light microscopy the presence of associated antigens in sections of formalin-fixed, paraffin-embedded tissue sections using IHC test methods recalled?

Yes. FDA published recall Z-3120-2017 on September 20, 2017. Reported hazard: A delay in transit may have contributed to nonconformity as the product was stored outside of defined shipping and handling temperature requirements.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail